ARTICLE | Clinical News
Herpes Simplex Virus regulatory update
July 27, 2015 7:00 AM UTC
FDA granted 510(k) clearance and a CLIA waiver to Theranos’ Herpes Simplex Virus, Type 1 test to screen for or diagnose HSV-1 infection. The test detects circulating HSV-1 IgG antibodies from finger s...